XML 60 R46.htm IDEA: XBRL DOCUMENT v3.25.2
Stock-based Compensation - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Mar. 14, 2025
Mar. 13, 2025
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                
Aggregate inducement awards outstanding     2,142,900     2,142,900    
Number of options, outstanding     5,148,374     5,148,374    
Common stock, shares outstanding     75,803,251     75,803,251   75,100,763
Weighted average exercise price, issued           $ 6.95    
Stock-based compensation expense recognized     $ 5,253   $ 5,430 $ 8,679 $ 9,119  
Nominal amount of expense in relation to ESPP recognized       $ 186        
Accrued expenses     14,797     14,797   $ 12,829
Unrecognized stock-based compensation expense related to unvested options granted     $ 17,200     $ 17,200    
Weighted average period for recognition of unvested options granted           2 years 10 months 24 days    
Estimated ESPP awards                
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                
Nominal amount of expense in relation to ESPP recognized           $ 100    
Nominal amount of expense in relation to ESPP           34,017    
Weighted average period for recognition of unvested options granted           2 years 9 months 18 days    
RSUs                
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                
Number of other than options, outstanding     60,000     60,000    
Number of shares, granted           5,274,500    
Stock-based compensation expense recognized     $ 3,600   2,700 $ 5,400 4,800  
Unrecognized stock-based compensation expense related to unvested options granted     34,100     $ 34,100    
Directors' Deferred Share Unit Plan                
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                
Number of shares, vested           190,917    
Stock-based compensation expense recognized     200   200 $ 200 600  
Accrued expenses     $ 1,300     $ 1,300    
Stock Option                
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                
Number of options, outstanding     1,832,900     1,832,900    
Number of shares, granted           1,242,550    
Stock-based compensation expense recognized     $ 1,600   $ 2,700 $ 3,200 $ 4,300  
Performance shares units                
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                
Vesting percentage           200.00%    
Number of other than options, outstanding     250,000     250,000    
Number of shares, granted           250,000    
Vesting period           36 months    
Requisite service period           36 months    
Performance shares units | Tranche One                
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                
Number of shares, granted           1,973,000    
Performance shares units | Tranche Two                
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                
Number of shares, granted           3,946,000    
MindMed Stock Option Plan                
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                
Vesting percentage   15.00%       15.00%    
Number of shares, granted 0              
Vesting rights, description           Prior to March 14, 2025, the Company was authorized to issue such number of equity awards equal to 15% of the Company’s issued and outstanding Common Shares under the terms of the MindMed Stock Option Plan (the “Stock Option Plan”), together with Common Shares that were issuable pursuant to outstanding awards or grants under any other compensation or incentive mechanism involving the issuance or potential issuance of Common Shares, including the MindMed Performance and Restricted Share Unit Plan (the “PRSU Plan”) and ESPP.    
MindMed Stock Option Plan | Maximum                
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                
Common stock, shares outstanding     9,318,090     9,318,090    
MindMed Stock Option Plan | Restricted Share Unit Awards and Performance Share Unit Awards                
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                
Common stock, shares outstanding     5,817,111     5,817,111    
MindMed Stock Option Plan | Stock Option                
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                
Common stock, shares outstanding     3,500,979     3,500,979    
2025 Equity Incentive Plan                
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                
Common Shares reserved for issuance     4,500,000     4,500,000    
2025 Equity Incentive Plan | RSUs                
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                
Number of shares, granted           0    
2025 Equity Incentive Plan | Stock Option                
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                
Number of shares, granted           375,935    
PRSU Plan                
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                
Vesting percentage           15.00%    
Number of shares, granted 0